trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Breast Neoplasms D001943 24 associated lipids
Neoplasms D009369 13 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Inflammation D007249 119 associated lipids
Reperfusion Injury D015427 65 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Diabetes Mellitus, Experimental D003921 85 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Body Weight D001835 333 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Carcinoma D002277 18 associated lipids
Ureteral Obstruction D014517 10 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Hypersensitivity D006967 22 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Mizutani H et al. Romidepsin (FK228), a potent histone deacetylase inhibitor, induces apoptosis through the generation of hydrogen peroxide. 2010 Cancer Sci. pmid:20624163
Yang J et al. A novel mechanism involving coordinated regulation of nuclear levels and acetylation of NF-YA and Bcl6 activates RGS4 transcription. 2010 J. Biol. Chem. pmid:20630860
Wang XH et al. S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer. 2010 Am. J. Pathol. pmid:20581057
Terhune SS et al. Human cytomegalovirus UL29/28 protein interacts with components of the NuRD complex which promote accumulation of immediate-early RNA. 2010 PLoS Pathog. pmid:20585571
Dai X et al. Somatic nucleus reprogramming is significantly improved by m-carboxycinnamic acid bishydroxamide, a histone deacetylase inhibitor. 2010 J. Biol. Chem. pmid:20566633
Sudo H and Baas PW Acetylation of microtubules influences their sensitivity to severing by katanin in neurons and fibroblasts. 2010 J. Neurosci. pmid:20505088
Yoshizawa Y et al. Impaired active demethylation of the paternal genome in pronuclear-stage rat zygotes produced by in vitro fertilization or intracytoplasmic sperm injection. 2010 Mol. Reprod. Dev. pmid:19743475
Bui HT et al. Effect of trichostatin A on chromatin remodeling, histone modifications, DNA replication, and transcriptional activity in cloned mouse embryos. 2010 Biol. Reprod. pmid:20505166
Kim IA et al. HDAC inhibitor-mediated radiosensitization in human carcinoma cells: a general phenomenon? 2010 J. Radiat. Res. pmid:20505264
Wu Y et al. Constitutive and tumor necrosis factor-alpha-stimulated activation of nuclear factor-kappaB in immortalized endometriotic cells and their suppression by trichostatin A. 2010 Gynecol. Obstet. Invest. pmid:20130413
Zhao J et al. Histone deacetylase inhibitors improve in vitro and in vivo developmental competence of somatic cell nuclear transfer porcine embryos. 2010 Cell Reprogram pmid:20132015
Chuang C et al. Acetylation of RNA processing proteins and cell cycle proteins in mitosis. 2010 J. Proteome Res. pmid:20812760
Martinez-Diaz MA et al. Pre- and postimplantation development of swine-cloned embryos derived from fibroblasts and bone marrow cells after inhibition of histone deacetylases. 2010 Cell Reprogram pmid:20132016
Yang F et al. Trichostatin A and 5-azacytidine both cause an increase in global histone H4 acetylation and a decrease in global DNA and H3K9 methylation during mitosis in maize. 2010 BMC Plant Biol. pmid:20718950
Host L et al. Inhibition of histone deacetylases in rats self-administering cocaine regulates lissencephaly gene-1 and reelin gene expression, as revealed by microarray technique. 2010 J. Neurochem. pmid:20132486
Emonds E et al. Molecular determinants of the antitumor effects of trichostatin A in pancreatic cancer cells. 2010 World J. Gastroenterol. pmid:20419833
Bao BY et al. Down-regulation of NF-kappaB signals is involved in loss of 1alpha,25-dihydroxyvitamin D3 responsiveness. 2010 J. Steroid Biochem. Mol. Biol. pmid:20206692
Tian F et al. NMDA receptor activation induces differential epigenetic modification of Bdnf promoters in hippocampal neurons. 2010 Amino Acids pmid:19565326
Liu YL et al. Autophagy potentiates the anti-cancer effects of the histone deacetylase inhibitors in hepatocellular carcinoma. 2010 Autophagy pmid:20962572
McKenzie L et al. p53-dependent repression of polo-like kinase-1 (PLK1). 2010 Cell Cycle pmid:20962589
Mittal MK et al. Mode of action of the retrogene product SNAI1P, a SNAIL homolog, in human breast cancer cells. 2010 Mol. Biol. Rep. pmid:19277896
Trtková K et al. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor. 2010 Cancer Biomark pmid:21178266
Spin JM et al. Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300. 2010 PLoS ONE pmid:21179216
Pollack BP et al. Ultraviolet radiation-induced transcription is associated with gene-specific histone acetylation. 2009 May-Jun Photochem. Photobiol. pmid:19076306
Chen Z et al. BCL11A represses HBG transcription in K562 cells. 2009 Mar-Apr Blood Cells Mol. Dis. pmid:19153051
Wang L et al. Using histone deacetylase inhibitors to enhance Foxp3(+) regulatory T-cell function and induce allograft tolerance. 2009 Mar-Apr Immunol. Cell Biol. pmid:19172156
Allritz C et al. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels. 2009 Jul-Aug Neurochem. Int. pmid:19428803
Yang X et al. CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells. 2009 PLoS ONE pmid:19340297
Slattery EL et al. Epigenetic influences on sensory regeneration: histone deacetylases regulate supporting cell proliferation in the avian utricle. 2009 J. Assoc. Res. Otolaryngol. pmid:19340485
Vilar E et al. Gene expression patterns in mismatch repair-deficient colorectal cancers highlight the potential therapeutic role of inhibitors of the phosphatidylinositol 3-kinase-AKT-mammalian target of rapamycin pathway. 2009 Clin. Cancer Res. pmid:19351759
Lugrin J et al. Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF) expression by targeting MIF gene transcription through a local chromatin deacetylation. 2009 Biochim. Biophys. Acta pmid:19747950
Cervera RP et al. Trichostatin A affects histone acetylation and gene expression in porcine somatic cell nucleus transfer embryos. 2009 Theriogenology pmid:19765811
Diplas AI et al. Demonstration of all-or-none loss of imprinting in mRNA expression in single cells. 2009 Nucleic Acids Res. pmid:19767614
Chen Y et al. 3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment. 2009 Eur J Med Chem pmid:19136179
Cowell RM et al. Identification of novel targets for PGC-1alpha and histone deacetylase inhibitors in neuroblastoma cells. 2009 Biochem. Biophys. Res. Commun. pmid:19118529
Wiesen JL and Tomasi TB Dicer is regulated by cellular stresses and interferons. 2009 Mol. Immunol. pmid:19118902
Riester D et al. Non-isotopic dual parameter competition assay suitable for high-throughput screening of histone deacetylases. 2009 Bioorg. Med. Chem. Lett. pmid:19457659
Kim HN et al. Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKL. 2009 Eur. J. Pharmacol. pmid:19766111
Woodfield GW et al. Interaction of TFAP2C with the estrogen receptor-alpha promoter is controlled by chromatin structure. 2009 Clin. Cancer Res. pmid:19458056
Thiel A et al. 15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. 2009 Clin. Cancer Res. pmid:19584167
Rahim R and Strobl JS Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells. 2009 Anticancer Drugs pmid:19584707
Shao GB et al. Effect of trychostatin A treatment on gene expression in cloned mouse embryos. 2009 Theriogenology pmid:19246084
Cunneen TS et al. In vitro effects of histone deacetylase inhibitors and mitomycin C on tenon capsule fibroblasts and conjunctival melanoma cells. 2009 Arch. Ophthalmol. pmid:19365017
Charrier C et al. Synthesis and modeling of new benzofuranone histone deacetylase inhibitors that stimulate tumor suppressor gene expression. 2009 J. Med. Chem. pmid:19385600
Łuczak MW and Jagodziński PP Trichostatin A down-regulates CYP19 transcript and protein levels in MCF-7 breast cancer cells. 2009 Biomed. Pharmacother. pmid:18602794
Auer D et al. Expression of coxsackie-adenovirus receptor is related to estrogen sensitivity in breast cancer. 2009 Breast Cancer Res. Treat. pmid:18618240
Tan HH and Porter AG p21(WAF1) negatively regulates DNMT1 expression in mammalian cells. 2009 Biochem. Biophys. Res. Commun. pmid:19275888
Gavin DP et al. Histone deacetylase inhibitors and candidate gene expression: An in vivo and in vitro approach to studying chromatin remodeling in a clinical population. 2009 J Psychiatr Res pmid:19187942
Sasaki K et al. Real-time imaging of histone H4 hyperacetylation in living cells. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805290
Gibbs A et al. Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19805354